A Non-randomized, Open-label, Phase II Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 14 Nov 2022

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

03 Nov 2022 Results(n=31: from two phase 2 studies (E1201 and E1202 NCT02148133, NCT02404025) assessing the effect of eltrombopag on cytomorphologic findings in Patients With Aplastic Anemia published in the American Journal of Clinical Pathology
03 Oct 2017 Status changed from active, no longer recruiting to completed.
08 Aug 2016 Planned End Date changed from 1 Aug 2017 to 1 Oct 2017.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com